A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men.
Saved in:
| Title: | A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men. |
|---|---|
| Authors: | Sakamoto, Kei1 (AUTHOR) Kei.Sakamoto@astrazeneca.com, Matsuki, Shunji2 (AUTHOR), Irie, Shin2 (AUTHOR), Uchida, Naoki3 (AUTHOR), Hayashi, Nobuya1 (AUTHOR), Horiuchi, Masato1 (AUTHOR), Ren, Song4 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Oct2020, Vol. 9 Issue 7, p833-840. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.775 |
